AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Photocure ASA

Share Issue/Capital Change Jun 14, 2021

3714_rns_2021-06-14_4dceaa60-5417-455f-8d8c-5ad05e040f36.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

Photocure ASA: Share capital increase registered

Photocure ASA: Share capital increase registered

Oslo, Norway, 14 June 2021: Reference is made to the stock exchange release by

Photocure ASA ("Photocure" or the "Company") published on 7 June 2021 regarding

a share capital increase following the exercise of share options.

The issuance of 98,251 new shares has been registered with the Norwegian

Register of Business Enterprises. Following registration, the share capital of

Photocure is NOK 13,459,160 divided into 26,918,320 shares, each share having a

par value of NOK 0.50 and carrying one vote in the Company's general meeting.

For further information, please contact:

Photocure

CFO Erik Dahl

Tel: +47 450 55 000

Email: [email protected]

About Photocure ASA

Photocure: The Bladder Cancer Company delivers transformative solutions to

improve the lives of bladder cancer patients. Our unique technology, making

cancer cells glow bright pink, has led to better health outcomes for patients

worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo

Stock Exchange (OSE: PHO). For more information, please visit us at

www.photocure.com, www.hexvix.com or www.cysview.com

All trademarks mentioned in this release are protected by law and are registered

trademarks of Photocure ASA.

This information is subject to the disclosure requirements pursuant to sections

5-12 of the Norwegian Securities Trading Act.

Talk to a Data Expert

Have a question? We'll get back to you promptly.